WEECO Pharma
WEECO Pharma is a Germany-based B2B pharmaceutical wholesaler founded in 2019 that distributes EU-GDP/GMP-certified medical cannabis flowers, proprietary SEDDS extracts, and pharmacy-compounded dosage forms to pharmacies across Germany, Austria, and Switzerland, operating as a subsidiary of SYNBIOTIC SE.
- Company typePrivate
- Founded2019
- HeadquartersHildesheim, Germany
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What WEECO Pharma does
WEECO Pharma GmbH is a Hildesheim, Germany-based pharmaceutical wholesale company founded in 2019 and operating as a subsidiary of SYNBIOTIC SE (Nasdaq First North Denmark: STENNO). The company specializes in B2B distribution of medical cannabis — flowers, extracts, and compounded dosage forms — to pharmacies across Germany, Austria, and Switzerland under EU-GDP and EU-GMP compliance. Its product architecture combines bulk wholesale flower SKUs (10g and 1kg units, strains including Purple Rain, Frosted Lemon Angel, White Widow, Tavira 23/1, Hella Jelly 14/1) with higher-margin proprietary platforms: the ASTRUM SEDDS self-emulsifying drug delivery system for improved cannabinoid bioavailability (via Stenocare partnership), and the Rezeptur-Kompass modular compounding system enabling pharmacies to prepare patient-individual suppositories, transdermal creams, lozenges, capsules, and adjusted extracts. The company holds MedCan-Erlaubnis gem. §4 MedCanG, wholesale permit gem. §52a AMG, EU-GDP and EU-GMP certifications, with planned expansion to §72 AMG import and §13 AMG manufacturing permits.
Go-to-market is field-sales-led, with a nationwide sales team serving pharmacies directly, distribution through major channel partner Aurora Deutschland GmbH, and lead generation via ICBC Berlin and Expopharm trade shows. Revenue is generated through per-unit wholesale pricing on flowers and extracts, plus demand-side services such as GDP/GMP-compliant import-export logistics, pharmacy staff training, and rezeptur consultation. WEECO actively cultivates international sourcing partnerships (Portugal, North Macedonia, Denmark via Stenocare, California) and product co-development agreements (BOLDER Arzneimittel for cannabis lozenges) to differentiate on formulation and supply diversity rather than commodity pricing. The company's strategic positioning is reinforced by SYNBIOTIC SE's portfolio restructuring to focus capital on the medical cannabis platform (WEECO, MH medical hemp, SOLIDMIND), while WEECO itself maintains operational independence under Managing Directors Johannes Gallois, Börge Diessel, and Tony Schröter.
WEECO Pharma firmographics
Firmographics- Name
- WEECO Pharma
- Legal name
- WEECO Pharma GmbH
- Website
- https://weeco.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- WEECO Pharma is a Germany-based B2B pharmaceutical wholesaler founded in 2019 that distributes EU-GDP/GMP-certified medical cannabis flowers, proprietary SEDDS extracts, and pharmacy-compounded dosage forms to pharmacies across Germany, Austria, and Switzerland, operating as a subsidiary of SYNBIOTIC SE.
- Ownership category
- akta.pro rank
WEECO Pharma industry classification
Industry- Product category
- Medical Cannabis Pharmaceutical Wholesale
- NAICS
- Drugs and Druggists' Sundries Merchant Wholesalers (42421)
- SIC
- Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)
- akta.pro primary industry
- Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience) (CRAOAHAG)
Keywords
Where WEECO Pharma is headquartered
LocationHeadquarters
- HQ city
- Hildesheim
- HQ country
- Germany
- HQ region
- Europe
Offices2 records
Markets served
WEECO Pharma business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales
Revenue model
- Cannabis Flower Wholesale: Wholesale distribution of medical cannabis flowers to pharmacies in Germany, Austria, and Switzerland. Products include various strains with defined THC and CBD content. Sales are B2B, requiring customer qualification and medical prescription.
- Cannabis Extracts Distribution: Distribution of EU-GMP compliant cannabis raw extracts and adjusted extracts (including WEECO ASTRUM products) for pharmaceutical compounding and direct patient use. Revenue generated through per-unit pricing.
- Compounding Base Materials: Supply of standardized galenic materials for pharmacy compounding including suppository bases, transdermal cream bases, lozenge components, and concentrated extracts for patient-specific formulations.
- GDP/GMP Compliant Import & Export Services: International trade services for medical cannabis, facilitating imports to Germany from certified producers and exports to international markets. Services include regulatory compliance, quality assurance documentation, and accelerated export processes.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Medical Cannabis Flowers - available in 10g and 1kg packaging units |
| Unit Pricing | Pay-as-you-go | Compounded Cannabis Products - pharmacy compounding materials |
Go-to-market motion2 records
Distribution channels4 records
Marketing channels4 records
WEECO Pharma product offering
Product offeringCore offering
WEECO Pharma GmbH is a pharmaceutical wholesaler that distributes EU-GMP and EU-GDP compliant medical cannabis flowers, raw extracts, and adjusted extracts (including the proprietary ASTRUM SEDDS-based extract line) to pharmacies and pharmaceutical wholesalers in Germany, Austria, and Switzerland. The portfolio is complemented by a modular Rezeptur-Kompass compounding system enabling pharmacies to produce patient-individual dosage forms such as lozenges, transdermal creams, suppositories, and capsules, along with related accessories like the O-Trap vaporizer.
Product overview
WEECO Pharma is a pharmaceutical wholesale company specializing in medical cannabis and cannabinoid-based medicines, serving pharmacies and pharmaceutical wholesalers in Germany, Austria, and Switzerland since 2019. The product portfolio centers on wholesale distribution of EU-GMP and GDP-compliant cannabis flowers and extracts, complemented by an innovative galenic formulation system. The core offering includes various cannabis flower strains (Purple Rain, Frosted Lemon Angel, White Widow, Tavira 23/1, Hella Jelly 14/1) alongside the proprietary ASTRUM extract platform using SEDDS technology for improved bioavailability. A modular prescription system (Rezeptur-Kompass) enables pharmacies to prepare patient-individual dosage forms including lozenges, transdermal creams, suppositories, and capsules from standardized galenics. The company operates as a B2B partner exclusively supplying pharmacies and healthcare professionals.
Differentiator
Problem solved
Functional benefit
Brands
- WEECO ASTRUM: Cannabis extract product line using SEDDS technology for improved bioavailability, including WEECO ASTRUM 10-10 extract (10mg/ml THC and 10mg/ml CBD in 30ml bottle)
- WEECO MKD HJY 14/1
- WEECO Tavira 23/1
Products and services
- WEECO ASTRUM 10-10 Extrakt Cannabis oil extract containing 10mg/ml THC and 10mg/ml CBD in a 30ml bottle, based on patented ASTRUM SEDDS technology that improves bioavailability through a water-soluble, self-emulsifying carrier system. Distributed via partnership with Stenocare A/S to pharmacies in Germany.
- Cannabisextrakt-Lutschpastille THC-containing medicated lozenge for oral cannabinoid administration, developed as a patient-individual prescription product in collaboration with BOLDER Arzneimittel. Provides rapid, flavored dosing without social stigma for patients.
- Transdermale Cannabinoid-Cremes Transdermal cannabinoid creams enabling controlled active ingredient absorption through the skin, with up to 100mg THC or CBD per pump dose for local or systemic application. Compounded by pharmacies from WEECO base materials.
- Cannabinoid-Zäpfchen Cannabis suppositories for rectal or vaginal administration with consistent drug release and controllable dosing up to 100mg THC or CBD per unit. Suitable for patients with limited oral intake, bypassing the gastrointestinal tract.
- Cannabinoid-Kapseln Cannabis capsules for systemic therapy with reproducible active ingredient quantity, providing precise, patient-individual dosing up to 50mg THC or CBD per capsule for continuous medication.
- Eingestellter Cannabisextrakt Adjusted cannabis extract serving as a base substance for numerous pharmacy formulations, with maximum concentration up to 250mg THC or CBD per ml, versatile for further processing into multiple dosage forms.
- PIEX2 Cannabisextrakt Highly concentrated pure cannabis extract with 70% THC content, free from fillers or carrier oils, supplied as a base substance for patient-individual pharmacy preparations including lozenges.
- WEECO Purple Rain Hybrid Sativa-dominant medical cannabis flowers with 24% THC and CBD under 1%, supplied in EU-GMP compliant pharmaceutical quality for pharmacy wholesale.
- WEECO Frosted Lemon Angel Hybrid medical cannabis flowers with 23% THC content in EU-GMP compliant pharmaceutical quality, supplied to pharmacies in 10g and 1kg packaging.
- WEECO White Widow Medical cannabis flowers with 18% THC content in EU-GMP compliant pharmaceutical quality, supplied to pharmacies.
- WEECO Tavira 23/1 Medical cannabis flowers with indica-dominant genetics (Sour Punch) with up to 23% THC and CBD under 1%, produced in Portugal, E-beam irradiated, available in 250g and 1kg packaging.
- WEECO Hella Jelly 14/1 (WEECO MKD HJY 14/1) Sativa-dominant medical cannabis flowers with 14% THC and CBD under 1%, developed from Humboldt Seed Company genetics and cultivated in North Macedonia under organic Living Soil conditions.
- Medizinische Cannabisblüten (Sonstige Sorten) Various medical cannabis flower strains including THC-dominant, CBD-dominant, and balanced varieties, EU-GMP and GDP compliant, available in 10g and 1kg packaging for pharmacy wholesale supply.
- O-Trap Vaporizer device for medical cannabis flower inhalation application, distributed alongside WEECO's cannabis flower portfolio for pharmacy patients.
- GDP/GMP-konformer Import und Distribution EU-GDP and EU-GMP compliant international trade services for medical cannabis, facilitating imports to Germany from certified producers and exports to international markets, including regulatory compliance, quality assurance documentation, and accelerated export processes.
Quantifiable outcome
- ASTRUM SEDDS technology improves bioavailability of cannabinoid active ingredients compared to conventional oil-based extracts
- +1 more outcomes
Companies that use WEECO Pharma
Customer profileNamed customers3 records
Segments3 records
Ideal customer profiles2 records
WEECO Pharma technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
WEECO Pharma partnerships and signals
Strategic signalPartnerships
Five partnerships are on record, tiered core, minor and major.
- Stenocare A/ScoreStrategic partnership for launching ASTRUM oil products in Germany. Stenocare, a Danish medical cannabis company listed on Nasdaq First North, provides EU-GMP certified cannabis oils based on their patented ASTRUM technology. WEECO Pharma leverages regulatory expertise and distribution network for German market entry. First product (WEECO ASTRUM 10-10 Extract with 10mg/ml THC and 10mg/ml CBD in 30ml bottles) launched February 2026.
- Canymed (Grünhorn)minorJoint exhibition at Expopharm 2025 in Düsseldorf. Canymed, a cannabis company, co-exhibited with WEECO at Europe's largest pharmacy trade show to present new cannabis formulations including lozenges, transdermal creams, and WEECO ASTRUM products.
- BOLDER Arzneimittel GmbH & Co. KGcoreCollaboration for development of medical cannabis lozenges (Lutschpastillen) - a first in the German market. BOLDER, a market leader in pharmaceutical lozenge manufacturing with over 100 years of experience and production of over 1 billion lozenges annually, developed the lozenge formulation. WEECO supplies the cannabis extract (PIEX2) base material with 70% THC content. Product launched Q2 2025.
- MH medical hemp GmbHcorePartnership within the SYNBIOTIC SE group for medical hemp products. MH medical hemp specializes in CBD extraction, production, and worldwide distribution of hemp-based cannabinoids. Supplies additional components for cannabis lozenge formulations alongside WEECO.
- Aurora Deutschland GmbHmajorAurora Deutschland GmbH, Germany's market leader in the medical cannabis flower segment, distributes WEECO products including the WEECO 25/1 medicinal cannabis flowers. Aurora is one of the leading importers, manufacturers, and wholesalers of medical cannabis in Germany.
Scale indicators4 records
Recent moves6 records
Expansion highlights6 records
WEECO Pharma competitors and assessment
Company assessmentDirect peers
- Cannamedical Pharma GmbH: Cannamedical is a Cologne-based medical cannabis wholesaler and importer supplying pharmacies across Germany with EU-GMP cannabis flowers and extracts, directly comparable to WEECO's core distribution business.
- Four 20 Pharma GmbH: Four 20 Pharma is a German medical cannabis wholesaler distributing EU-GMP cannabis flowers and extracts to pharmacies — operating in the same regulated wholesale-to-pharmacy channel as WEECO.
- Demecan: Demecan is a German producer and wholesaler of medical cannabis flowers serving pharmacies under EU-GMP standards — directly overlapping with WEECO's core flower distribution and pharmacy wholesale business in Germany.
- Fette Pharma GmbH: Fette Pharma is a German importer and wholesaler of medical cannabis and cannabinoid APIs, serving pharmacies and compounders under German pharmaceutical licensing — closely comparable to WEECO's wholesale and import operations.
- Aurora Deutschland GmbH: Aurora Deutschland is described as Germany's market leader in medical cannabis flower wholesale and is simultaneously a WEECO distribution partner and a direct competitor in the same product category serving the same German pharmacy customers.
- Nimbus Health GmbH: Nimbus Health is a German medical cannabis platform offering wholesale distribution plus a digital patient-pharmacy channel — overlapping with WEECO's wholesale model while adding a downstream telehealth layer WEECO does not operate.
Emerging players
- Canymed (Grünhorn): Canymed is a German cannabis company that co-exhibited with WEECO at Expopharm 2025 and develops new cannabis formulations including lozenges, transdermal creams, and extracts — overlapping with WEECO's compounding and extract portfolio.
- Stenocare A/S: Stenocare is a Danish medical cannabis producer and partner of WEECO for ASTRUM oil distribution in Germany; it operates as both a strategic partner and a competing EU-GMP producer in adjacent European markets.
Broad incumbents
- Sanity Group GmbH: Sanity Group is a broader European cannabis platform combining medical wholesale (via its subsidiary), cultivation, and consumer brands — operating at greater scale and broader scope than WEECO's medical-focused wholesale niche.
- Tilray Brands: Tilray is a globally listed cannabis major with a German and European medical cannabis wholesale footprint — competing with WEECO in flower and extract distribution at much greater scale and broader geographic reach.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
WEECO Pharma social profiles
Digital presenceWEECO Pharma compliance and trust
Trust signalCompliance7 records
WEECO Pharma financial estimates
Financial estimateRevenue estimate
Valuation estimate
WEECO Pharma leadership team
Management profileNumber of profiles
Profiles4 records
WEECO Pharma funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
WEECO Pharma M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about WEECO Pharma
What does WEECO Pharma do?
WEECO Pharma GmbH is a pharmaceutical wholesaler that distributes EU-GMP and EU-GDP compliant medical cannabis flowers, raw extracts, and adjusted extracts (including the proprietary ASTRUM SEDDS-based extract line) to pharmacies and pharmaceutical wholesalers in Germany, Austria, and Switzerland. The portfolio is complemented by a modular Rezeptur-Kompass compounding system enabling pharmacies to produce patient-individual dosage forms such as lozenges, transdermal creams, suppositories, and capsules, along with related accessories like the O-Trap vaporizer.
Is WEECO Pharma a public or private company?
WEECO Pharma is a private company. It is classified as corporate owned and is currently operating.
When was WEECO Pharma founded?
WEECO Pharma was founded in 2019. It employs 11 to 50 people.
Where is WEECO Pharma based?
WEECO Pharma is headquartered in Hildesheim, Germany, in the Europe region.
How does WEECO Pharma make money?
Four revenue lines are on record. Cannabis Flower Wholesale is the primary driver. The others are cannabis Extracts Distribution, compounding Base Materials and GDP/GMP Compliant Import & Export Services.
Who are WEECO Pharma's main competitors?
Direct peers on record are Cannamedical Pharma GmbH, Four 20 Pharma GmbH, Demecan, Fette Pharma GmbH, Aurora Deutschland GmbH and Nimbus Health GmbH. Emerging players are Canymed (Grünhorn) and Stenocare A/S. Broad incumbents are Sanity Group GmbH and Tilray Brands.
Does WEECO Pharma have an API?
No public API is recorded for WEECO Pharma.
What industry is WEECO Pharma in?
WEECO Pharma's product category is Medical Cannabis Pharmaceutical Wholesale. Its primary akta.pro industry code is CRAOAHAG, Pharmacy Front-End & Sundries Distribution (Health & Wellness, Personal Care, Convenience). Its NAICS code is 42421 and its SIC code is 5122.